JP5311340B2 - 新規なナノシリカ粒子の製造方法と用途 - Google Patents
新規なナノシリカ粒子の製造方法と用途 Download PDFInfo
- Publication number
- JP5311340B2 JP5311340B2 JP2008520630A JP2008520630A JP5311340B2 JP 5311340 B2 JP5311340 B2 JP 5311340B2 JP 2008520630 A JP2008520630 A JP 2008520630A JP 2008520630 A JP2008520630 A JP 2008520630A JP 5311340 B2 JP5311340 B2 JP 5311340B2
- Authority
- JP
- Japan
- Prior art keywords
- silica
- particles
- mps
- group
- particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002245 particle Substances 0.000 title claims abstract description 398
- 238000004519 manufacturing process Methods 0.000 title claims description 48
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 442
- UUEWCQRISZBELL-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS UUEWCQRISZBELL-UHFFFAOYSA-N 0.000 claims abstract description 225
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 180
- -1 silica compound Chemical group 0.000 claims abstract description 98
- DCQBZYNUSLHVJC-UHFFFAOYSA-N 3-triethoxysilylpropane-1-thiol Chemical compound CCO[Si](OCC)(OCC)CCCS DCQBZYNUSLHVJC-UHFFFAOYSA-N 0.000 claims abstract description 40
- IKYAJDOSWUATPI-UHFFFAOYSA-N 3-[dimethoxy(methyl)silyl]propane-1-thiol Chemical compound CO[Si](C)(OC)CCCS IKYAJDOSWUATPI-UHFFFAOYSA-N 0.000 claims abstract description 36
- RMKZLFMHXZAGTM-UHFFFAOYSA-N [dimethoxy(propyl)silyl]oxymethyl prop-2-enoate Chemical compound CCC[Si](OC)(OC)OCOC(=O)C=C RMKZLFMHXZAGTM-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000003550 marker Substances 0.000 claims abstract description 16
- 229910000077 silane Inorganic materials 0.000 claims abstract description 12
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims abstract description 11
- HKMVWLQFAYGKSI-UHFFFAOYSA-N 3-triethoxysilylpropyl thiocyanate Chemical compound CCO[Si](OCC)(OCC)CCCSC#N HKMVWLQFAYGKSI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 109
- 239000000126 substance Substances 0.000 claims description 93
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 72
- 238000000034 method Methods 0.000 claims description 71
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 claims description 71
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 65
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 61
- 238000000684 flow cytometry Methods 0.000 claims description 42
- 239000002344 surface layer Substances 0.000 claims description 39
- 108090000623 proteins and genes Proteins 0.000 claims description 37
- 102000004169 proteins and genes Human genes 0.000 claims description 36
- 239000011148 porous material Substances 0.000 claims description 32
- 238000009826 distribution Methods 0.000 claims description 30
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 28
- 229910021529 ammonia Inorganic materials 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 22
- 239000011324 bead Substances 0.000 claims description 17
- 125000003729 nucleotide group Chemical group 0.000 claims description 17
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims description 16
- 239000002773 nucleotide Substances 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 12
- 150000002540 isothiocyanates Chemical class 0.000 claims description 12
- 238000003556 assay Methods 0.000 claims description 10
- 108091034117 Oligonucleotide Proteins 0.000 claims description 9
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 9
- 108020004707 nucleic acids Proteins 0.000 claims description 9
- 102000039446 nucleic acids Human genes 0.000 claims description 9
- 150000007523 nucleic acids Chemical class 0.000 claims description 9
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid group Chemical group C(CCCCC)(=O)O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 8
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 6
- 239000000523 sample Substances 0.000 claims description 5
- 238000004113 cell culture Methods 0.000 claims description 3
- 238000001668 nucleic acid synthesis Methods 0.000 claims description 3
- 238000001243 protein synthesis Methods 0.000 claims description 3
- 230000014616 translation Effects 0.000 claims description 3
- 150000003923 2,5-pyrrolediones Chemical class 0.000 claims description 2
- 150000004677 hydrates Chemical class 0.000 claims 2
- 239000003814 drug Substances 0.000 abstract description 11
- 238000012360 testing method Methods 0.000 abstract description 9
- 238000012113 quantitative test Methods 0.000 abstract description 5
- 229940124597 therapeutic agent Drugs 0.000 abstract description 5
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 239000000032 diagnostic agent Substances 0.000 abstract description 4
- 229940039227 diagnostic agent Drugs 0.000 abstract description 4
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 116
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 113
- 238000006243 chemical reaction Methods 0.000 description 80
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 70
- 239000008188 pellet Substances 0.000 description 63
- 238000002360 preparation method Methods 0.000 description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 39
- 235000019441 ethanol Nutrition 0.000 description 38
- 239000012153 distilled water Substances 0.000 description 32
- 239000000975 dye Substances 0.000 description 29
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 27
- 230000015572 biosynthetic process Effects 0.000 description 27
- 239000002105 nanoparticle Substances 0.000 description 24
- 239000007850 fluorescent dye Substances 0.000 description 23
- 238000005755 formation reaction Methods 0.000 description 23
- 238000009739 binding Methods 0.000 description 21
- 150000003573 thiols Chemical class 0.000 description 21
- 230000027455 binding Effects 0.000 description 20
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 20
- 238000005406 washing Methods 0.000 description 19
- 238000005119 centrifugation Methods 0.000 description 17
- 239000011521 glass Substances 0.000 description 16
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 14
- 239000000463 material Substances 0.000 description 14
- 238000002156 mixing Methods 0.000 description 14
- 230000001419 dependent effect Effects 0.000 description 13
- 230000004048 modification Effects 0.000 description 13
- 238000012986 modification Methods 0.000 description 13
- 239000012114 Alexa Fluor 647 Substances 0.000 description 12
- 125000003277 amino group Chemical group 0.000 description 11
- 238000007796 conventional method Methods 0.000 description 11
- 238000007306 functionalization reaction Methods 0.000 description 11
- 239000002096 quantum dot Substances 0.000 description 11
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 10
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 239000005090 green fluorescent protein Substances 0.000 description 10
- 238000002372 labelling Methods 0.000 description 10
- 125000003396 thiol group Chemical group [H]S* 0.000 description 10
- 239000000427 antigen Substances 0.000 description 9
- 102000036639 antigens Human genes 0.000 description 9
- 108091007433 antigens Proteins 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 238000002073 fluorescence micrograph Methods 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 241000283707 Capra Species 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 238000004166 bioassay Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000011002 quantification Methods 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 241001494479 Pecora Species 0.000 description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
- 230000002776 aggregation Effects 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 238000001000 micrograph Methods 0.000 description 6
- 239000002086 nanomaterial Substances 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 238000003980 solgel method Methods 0.000 description 6
- 238000001179 sorption measurement Methods 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 5
- 238000004220 aggregation Methods 0.000 description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
- 238000010306 acid treatment Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- VWNQJLIVSOOFBX-UHFFFAOYSA-L ruthenium(2+);dichloride;hexahydrate Chemical compound O.O.O.O.O.O.Cl[Ru]Cl VWNQJLIVSOOFBX-UHFFFAOYSA-L 0.000 description 4
- 238000007711 solidification Methods 0.000 description 4
- 230000008023 solidification Effects 0.000 description 4
- 238000013268 sustained release Methods 0.000 description 4
- 239000012730 sustained-release form Substances 0.000 description 4
- QQQSFSZALRVCSZ-UHFFFAOYSA-N triethoxysilane Chemical compound CCO[SiH](OCC)OCC QQQSFSZALRVCSZ-UHFFFAOYSA-N 0.000 description 4
- DQZNLOXENNXVAD-UHFFFAOYSA-N trimethoxy-[2-(7-oxabicyclo[4.1.0]heptan-4-yl)ethyl]silane Chemical compound C1C(CC[Si](OC)(OC)OC)CCC2OC21 DQZNLOXENNXVAD-UHFFFAOYSA-N 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- VWFRSNKRTNUMET-UHFFFAOYSA-N 2-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]-5-(2,5-dioxopyrrolidin-1-yl)oxycarbonylbenzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C(C(=C1)C([O-])=O)=CC=C1C(=O)ON1C(=O)CCC1=O VWFRSNKRTNUMET-UHFFFAOYSA-N 0.000 description 3
- 108010004729 Phycoerythrin Proteins 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000001268 conjugating effect Effects 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- 238000000799 fluorescence microscopy Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000000693 micelle Substances 0.000 description 3
- 238000005580 one pot reaction Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 239000010907 stover Substances 0.000 description 3
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 2
- KZEARGOESCNLLB-UHFFFAOYSA-N 3-triethoxysilylpropane-1-thiol Chemical compound CCO[Si](OCC)(OCC)CCCS.CCO[Si](OCC)(OCC)CCCS KZEARGOESCNLLB-UHFFFAOYSA-N 0.000 description 2
- QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 2
- HCDOULFCCCTGKL-UHFFFAOYSA-N O1C2CC(CCC21)CC[Si](OC)(OC)OC.O2C1CC(CCC12)CC[Si](OC)(OC)OC Chemical compound O1C2CC(CCC21)CC[Si](OC)(OC)OC.O2C1CC(CCC12)CC[Si](OC)(OC)OC HCDOULFCCCTGKL-UHFFFAOYSA-N 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 125000002228 disulfide group Chemical group 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 description 2
- 108010087904 neutravidin Proteins 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000000700 radioactive tracer Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- GHNFXFCVNHUNQY-UHFFFAOYSA-N 2-n-(2-aminoethyl)-5-trimethoxysilylpentane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCC(CN)NCCN GHNFXFCVNHUNQY-UHFFFAOYSA-N 0.000 description 1
- AHYFYQKMYMKPKD-UHFFFAOYSA-N 3-ethoxysilylpropan-1-amine Chemical compound CCO[SiH2]CCCN AHYFYQKMYMKPKD-UHFFFAOYSA-N 0.000 description 1
- ZXFNSBMXKNDSMV-UHFFFAOYSA-N 3-ethoxysilylpropane-1-thiol Chemical compound CCO[SiH2]CCCS ZXFNSBMXKNDSMV-UHFFFAOYSA-N 0.000 description 1
- AUDYZXNUHIIGRB-UHFFFAOYSA-N 3-thiophen-2-ylpyrrole-2,5-dione Chemical compound O=C1NC(=O)C(C=2SC=CC=2)=C1 AUDYZXNUHIIGRB-UHFFFAOYSA-N 0.000 description 1
- IHOYHKVQNJDASX-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS.CO[Si](OC)(OC)CCCS IHOYHKVQNJDASX-UHFFFAOYSA-N 0.000 description 1
- YMZMTOFQCVHHFB-UHFFFAOYSA-N 5-carboxytetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(C(O)=O)C=C1C([O-])=O YMZMTOFQCVHHFB-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 238000004438 BET method Methods 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229930182474 N-glycoside Natural products 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010043958 Peptoids Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 229910018557 Si O Inorganic materials 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000011091 antibody purification Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000013590 bulk material Substances 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- DHCWLIOIJZJFJE-UHFFFAOYSA-L dichlororuthenium Chemical compound Cl[Ru]Cl DHCWLIOIJZJFJE-UHFFFAOYSA-L 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- ADALIFAVBBCNGP-UHFFFAOYSA-N heptadecan-1-amine;hydrochloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCC[NH3+] ADALIFAVBBCNGP-UHFFFAOYSA-N 0.000 description 1
- 150000004687 hexahydrates Chemical class 0.000 description 1
- LBGWVCPLLFAGRI-UHFFFAOYSA-N hexane hydrate Chemical compound O.CCCCCC.CCCCCC LBGWVCPLLFAGRI-UHFFFAOYSA-N 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000012770 industrial material Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000029226 lipidation Effects 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- ARYZCSRUUPFYMY-UHFFFAOYSA-N methoxysilane Chemical compound CO[SiH3] ARYZCSRUUPFYMY-UHFFFAOYSA-N 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000002127 nanobelt Substances 0.000 description 1
- 239000002135 nanosheet Substances 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 239000002070 nanowire Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 150000001282 organosilanes Chemical class 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000008298 phosphoramidates Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000001022 rhodamine dye Substances 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Inorganic materials [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 1
- 238000006884 silylation reaction Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011882 ultra-fine particle Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000000733 zeta-potential measurement Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/588—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/02—Polysilicates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/04—Polysiloxanes
- C08G77/06—Preparatory processes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/04—Polysiloxanes
- C08G77/22—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen
- C08G77/28—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen sulfur-containing groups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/109163—Inorganic standards or controls
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Materials Engineering (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Silicon Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Silicon Polymers (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008520630A JP5311340B2 (ja) | 2006-06-08 | 2007-06-07 | 新規なナノシリカ粒子の製造方法と用途 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006160107 | 2006-06-08 | ||
| JP2006160107 | 2006-06-08 | ||
| JP2008520630A JP5311340B2 (ja) | 2006-06-08 | 2007-06-07 | 新規なナノシリカ粒子の製造方法と用途 |
| PCT/JP2007/061587 WO2007142316A1 (fr) | 2006-06-08 | 2007-06-07 | Méthode de production d'une nouvelle nanoparticule de silice et application de la nanoparticule de silice |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2007142316A1 JPWO2007142316A1 (ja) | 2009-10-29 |
| JP5311340B2 true JP5311340B2 (ja) | 2013-10-09 |
Family
ID=38801562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008520630A Active JP5311340B2 (ja) | 2006-06-08 | 2007-06-07 | 新規なナノシリカ粒子の製造方法と用途 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8455255B2 (fr) |
| EP (1) | EP2031010B1 (fr) |
| JP (1) | JP5311340B2 (fr) |
| WO (1) | WO2007142316A1 (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8455255B2 (en) * | 2006-06-08 | 2013-06-04 | The University Of Tokushima | Method for production of novel nano silica particle and use of the nano silica particle |
| EP2233437A4 (fr) * | 2007-12-06 | 2016-07-27 | Univ Tokushima | Particules de silice nanofonctionnelles et leur procédé de fabrication |
| US20120108121A1 (en) * | 2009-06-30 | 2012-05-03 | Baran Jr Jimmie R | Transparent fluorescent structures with improved fluorescence using nanoparticles, methods of making, and uses |
| JP5671836B2 (ja) * | 2010-04-27 | 2015-02-18 | コニカミノルタ株式会社 | 有機蛍光色素内包シリカナノ粒子、その製造方法、及びそれを用いた生体物質標識剤 |
| US8584864B2 (en) | 2010-11-19 | 2013-11-19 | Coldcrete, Inc. | Eliminating screens using a perforated wet belt and system and method for cement cooling |
| EP2681286B1 (fr) * | 2011-02-28 | 2018-08-15 | Novan, Inc. | Particules de silice modifiées par des groupements s-nitrosothiols libérant de l'oxyde nitrique et procédés de fabrication associés |
| US8642214B2 (en) * | 2011-08-25 | 2014-02-04 | Uchicago Argonne, Llc | Silicon-carbonaceous encapsulated materials |
| US8845940B2 (en) | 2012-10-25 | 2014-09-30 | Carboncure Technologies Inc. | Carbon dioxide treatment of concrete upstream from product mold |
| US20140216303A1 (en) | 2013-02-04 | 2014-08-07 | Michael Lee | System and method of applying carbon dioxide during the production of concrete |
| US9388072B2 (en) | 2013-06-25 | 2016-07-12 | Carboncure Technologies Inc. | Methods and compositions for concrete production |
| US20160107939A1 (en) | 2014-04-09 | 2016-04-21 | Carboncure Technologies Inc. | Methods and compositions for concrete production |
| US9376345B2 (en) | 2013-06-25 | 2016-06-28 | Carboncure Technologies Inc. | Methods for delivery of carbon dioxide to a flowable concrete mix |
| US10927042B2 (en) | 2013-06-25 | 2021-02-23 | Carboncure Technologies, Inc. | Methods and compositions for concrete production |
| WO2015123769A1 (fr) | 2014-02-18 | 2015-08-27 | Carboncure Technologies, Inc. | Carbonatation de mélanges de ciment |
| WO2015154174A1 (fr) | 2014-04-07 | 2015-10-15 | Carboncure Technologies, Inc. | Capture de dioxyde de carbone intégrée |
| JP6709734B2 (ja) * | 2014-10-31 | 2020-06-17 | 信一郎 礒部 | アルコキシシリル基含有有機ｅｌ色素およびその製造方法 |
| US20180184950A1 (en) * | 2015-04-06 | 2018-07-05 | University Of Miami | Imaging device and method for detection of disease |
| AU2017249444B2 (en) | 2016-04-11 | 2022-08-18 | Carboncure Technologies Inc. | Methods and compositions for treatment of concrete wash water |
| AU2018288555A1 (en) | 2017-06-20 | 2020-01-30 | Carboncure Technologies Inc. | Methods and compositions for treatment of concrete wash water |
| JP7086894B2 (ja) * | 2019-06-05 | 2022-06-20 | 信越化学工業株式会社 | オルガノポリシロキサンおよびそれを含む活性エネルギー線硬化性組成物 |
| CN112300778B (zh) * | 2019-07-30 | 2023-11-03 | 国家纳米科学中心 | 一种圆偏振发光物质及其制备方法和应用 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0347840A (ja) * | 1989-04-18 | 1991-02-28 | Shin Etsu Chem Co Ltd | 球状ポリオルガノシルセスキオキサン微粒子及びその製造方法 |
| JPH03269020A (ja) * | 1990-03-19 | 1991-11-29 | Shin Etsu Chem Co Ltd | アクリロキシ基、メルカプト基含有シルセスキオキサン球状微粉末の製造方法 |
| JPH04114065A (ja) * | 1990-09-04 | 1992-04-15 | Agency Of Ind Science & Technol | 有機基修飾シリカ粒子、その製造方法および該粒子をフィラーとする樹脂組成物 |
| JPH04202325A (ja) * | 1990-11-29 | 1992-07-23 | Toray Ind Inc | 球状シリコーン微粒子 |
| WO2003002633A1 (fr) * | 2001-06-29 | 2003-01-09 | Nanomics Biosystems Pty, Ltd. | Synthese et utilisation de particules d'organosilice |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3642445A (en) * | 1970-04-30 | 1972-02-15 | Us Interior | Utilization of coal-burning power plant by-products |
| US4428895A (en) * | 1979-03-02 | 1984-01-31 | Blasch Precision Ceramics, Inc. | Composite inorganic structures and process of producing same |
| US4246209A (en) * | 1979-03-02 | 1981-01-20 | Ramu International | Freezing inorganic particulate slurries |
| US4683334A (en) * | 1985-04-30 | 1987-07-28 | E. I. Du Pont De Nemours & Company | Modified 8-ring zeolites as catalysts for conversion of methanol and ammonia to dimethylamine |
| DE3616133A1 (de) * | 1985-09-25 | 1987-11-19 | Merck Patent Gmbh | Kugelfoermige sio(pfeil abwaerts)2(pfeil abwaerts)-partikel |
| US4927749A (en) * | 1986-04-09 | 1990-05-22 | Jeanette Simpson | Reagent for cell separation |
| EP0438527A4 (en) * | 1988-10-14 | 1992-07-01 | Mallinckrodt, Inc. | Radiolabelled particulate composition |
| DE69112053D1 (de) * | 1991-07-22 | 1995-09-14 | Bracco Int Bv | Anwendung von Chelaten von Konjugaten mit paramagnetischen Metallen für Targetting. |
| AU2245795A (en) * | 1994-05-19 | 1995-12-18 | Minnesota Mining And Manufacturing Company | Polymeric article having improved hydrophilicity and a method of making the same |
| US6160067A (en) * | 1995-10-03 | 2000-12-12 | Dsm N.V. | Reactive silica particles, process for manufacturing the same, use of the same |
| JPH10264521A (ja) * | 1997-03-26 | 1998-10-06 | Mitsubishi Paper Mills Ltd | 可逆性感熱記録材料 |
| AUPP004497A0 (en) * | 1997-10-28 | 1997-11-20 | University Of Melbourne, The | Stabilized particles |
| JP2000239388A (ja) * | 1999-02-24 | 2000-09-05 | Pola Chem Ind Inc | メルカプト基を有する珪酸化合物 |
| US6417246B1 (en) * | 1999-09-21 | 2002-07-09 | Jenerica/Pentron Incorporated | Dental composite materials |
| EP1244719B1 (fr) * | 1999-10-28 | 2005-01-19 | 3M Innovative Properties Company | Compositions et produits constitues desdites compositions |
| US7195780B2 (en) * | 2002-10-21 | 2007-03-27 | University Of Florida | Nanoparticle delivery system |
| JP4132648B2 (ja) * | 2000-12-04 | 2008-08-13 | ポーラ化成工業株式会社 | 有機修飾シリカコーティング粉体及びその構成要因である有機修飾シリカ |
| US6787629B2 (en) * | 2001-11-02 | 2004-09-07 | Pentron Clinical Technologies, Llc | Dental resin materials, method of manufacture, and uses thereof |
| JP2005508493A (ja) * | 2001-06-28 | 2005-03-31 | アドヴァンスト リサーチ アンド テクノロジー インスティテュート、インコーポレイティッド | 多色量子ドット標識ビーズおよびそのコンジュゲートの製造方法 |
| EP1302514B1 (fr) * | 2001-10-09 | 2009-07-15 | Mitsubishi Chemical Corporation | Composition de revêtement durcissable par rayonnement |
| US6719535B2 (en) * | 2002-01-31 | 2004-04-13 | Eksigent Technologies, Llc | Variable potential electrokinetic device |
| JP2005526887A (ja) * | 2002-05-24 | 2005-09-08 | スリーエム イノベイティブ プロパティズ カンパニー | 油回収のための表面改質ナノ粒子の使用 |
| AU2002950953A0 (en) * | 2002-08-23 | 2002-09-12 | Genera Biosystems Pty Ltd | Coded nucleic acid carriers |
| US20060018966A1 (en) * | 2003-07-22 | 2006-01-26 | Lin Victor S | Antimicrobial mesoporous silica nanoparticles |
| DE10355409A1 (de) * | 2003-11-25 | 2005-06-30 | Magnamedics Gmbh | Sphärische, magnetische Silicagel-Träger mit vergrößerter Oberfläche für die Aufreinigung von Nukleinsäuren |
| DE102004011110A1 (de) | 2004-03-08 | 2005-09-22 | Merck Patent Gmbh | Verfahren zur Herstellung monodisperser SiO2-Partikel |
| EP1635359A3 (fr) * | 2004-09-09 | 2007-01-17 | Konica Minolta Medical & Graphic, Inc. | Panneau pour la conversion d'images obtenues par rayonnement |
| JP4982687B2 (ja) | 2004-12-09 | 2012-07-25 | 株式会社テクノネットワーク四国 | 標識分子含有シリカ球の調製方法 |
| JP4154388B2 (ja) | 2004-12-27 | 2008-09-24 | キヤノン株式会社 | 被対象物を透過した電磁波の状態を検出するための検出装置 |
| JP5400297B2 (ja) * | 2005-12-27 | 2014-01-29 | 古河電気工業株式会社 | 蛍光ナノシリカ粒子、ナノ蛍光材料、それを用いたバイオチップ及びそのアッセイ法 |
| US8455255B2 (en) * | 2006-06-08 | 2013-06-04 | The University Of Tokushima | Method for production of novel nano silica particle and use of the nano silica particle |
| WO2008018566A1 (fr) * | 2006-08-10 | 2008-02-14 | The Furukawa Electric Co., Ltd. | Particule de silice colloïdale contenant une substance absorbant la lumière, un nanomatériau absorbant la lumière, un kit de nanoperle de marquage d'absorption, et un procédé de détection ou de quantification de molécules biologiques utilisant la particule de silice colloïdale contenant un |
| EP2233437A4 (fr) * | 2007-12-06 | 2016-07-27 | Univ Tokushima | Particules de silice nanofonctionnelles et leur procédé de fabrication |
-
2007
- 2007-06-07 US US12/303,870 patent/US8455255B2/en active Active
- 2007-06-07 WO PCT/JP2007/061587 patent/WO2007142316A1/fr active Search and Examination
- 2007-06-07 JP JP2008520630A patent/JP5311340B2/ja active Active
- 2007-06-07 EP EP07744912.2A patent/EP2031010B1/fr not_active Not-in-force
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0347840A (ja) * | 1989-04-18 | 1991-02-28 | Shin Etsu Chem Co Ltd | 球状ポリオルガノシルセスキオキサン微粒子及びその製造方法 |
| JPH03269020A (ja) * | 1990-03-19 | 1991-11-29 | Shin Etsu Chem Co Ltd | アクリロキシ基、メルカプト基含有シルセスキオキサン球状微粉末の製造方法 |
| JPH04114065A (ja) * | 1990-09-04 | 1992-04-15 | Agency Of Ind Science & Technol | 有機基修飾シリカ粒子、その製造方法および該粒子をフィラーとする樹脂組成物 |
| JPH04202325A (ja) * | 1990-11-29 | 1992-07-23 | Toray Ind Inc | 球状シリコーン微粒子 |
| WO2003002633A1 (fr) * | 2001-06-29 | 2003-01-09 | Nanomics Biosystems Pty, Ltd. | Synthese et utilisation de particules d'organosilice |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2031010A1 (fr) | 2009-03-04 |
| US8455255B2 (en) | 2013-06-04 |
| EP2031010B1 (fr) | 2014-04-23 |
| US20100330582A1 (en) | 2010-12-30 |
| WO2007142316A1 (fr) | 2007-12-13 |
| EP2031010A4 (fr) | 2012-04-04 |
| JPWO2007142316A1 (ja) | 2009-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5311340B2 (ja) | 新規なナノシリカ粒子の製造方法と用途 | |
| JP5709292B2 (ja) | ナノ機能性シリカ粒子およびその製造方法 | |
| JP2008533214A (ja) | ナノ粒子捕捉球状複合体、それらの製造プロセスおよび使用 | |
| JPWO2010016289A1 (ja) | 量子ドットを含有する蛍光標識剤 | |
| JP2007506084A (ja) | ナノ粒子コンジュゲート及びその製造方法 | |
| JP4985541B2 (ja) | ナノ粒子内包シリカ、それを用いた生体物質の標識物質および生体物質の標識方法 | |
| US7875255B2 (en) | Nanoparticles comprising calcium phosphate and ethylene imine compositions and methods of production thereof | |
| JPWO2009066548A1 (ja) | 半導体ナノ粒子、それを用いた蛍光標識物質及び分子・細胞イメージング法 | |
| WO2016072341A1 (fr) | Procédé d'immunocoloration, et trousse de réactifs d'immunocoloration pour utilisation dans ledit procédé | |
| JP5202857B2 (ja) | 分散性が高く、非特異的吸着を防止した複合粒子、複合粒子コロイド、それを用いた分析試薬、及び複合粒子の製造方法 | |
| JP4107873B2 (ja) | 発光性微粒子 | |
| Dembele et al. | Zwitterionic silane copolymer for ultra-stable and bright biomolecular probes based on fluorescent quantum dot nanoclusters | |
| JP2006508095A (ja) | 粒子の生物活性化 | |
| Zhang et al. | One-step and high-density protein immobilization on epoxysilane-modified silica nanoparticles | |
| KR20160092406A (ko) | 친수성 고분자로 코팅된 형광 실리카 나노입자 및 이의 제조방법 | |
| KR101368076B1 (ko) | 수용액에서 우수한 분산성을 가지는 표면 개질된 형광 실리카 나노입자 및 그 제조방법 | |
| Woolley et al. | From particle to platelet: optimization of a stable, high brightness fluorescent nanoparticle based cell detection platform | |
| JP5168092B2 (ja) | 半導体ナノ粒子標識剤 | |
| US20050208087A1 (en) | Modified oxidic nano-particle with hydrophobic inclusions, method for the production and use of said particle | |
| WO2010004777A1 (fr) | Agent nanoparticulaire inorganique de marquage | |
| JP5224359B2 (ja) | カルボキシル基を有する有機色素分子を含有するシリカナノ粒子の製造方法、前記製造方法により得られたシリカナノ粒子、それを用いた標識試薬 | |
| WO2009144983A1 (fr) | Agent de marquage de nanoparticules inorganiques | |
| JP2004352542A (ja) | ナノ粒子で装飾された無機成形体及びその製造方法 | |
| WO2008062660A1 (fr) | Nanoagrégat de silicium luminescent, son procédé de fabrication et agent pour marquer une substance biologique | |
| Aguilar | Quantum Dots for Bioimaging |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100224 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121127 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121221 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130329 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130527 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130621 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130625 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5311340 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D04 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |